Park Ha Biological Technology (BYAH) Inventory (2023 - 2026)

Park Ha Biological Technology (BYAH) has reported Inventory for 4 consecutive years, with $104046.0 the latest figure, recorded in Q2 2026.

• Quarterly Inventory rose 3830.71% year-over-year to $104046.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $104046.0 (up 3830.71% YoY) and the FY2025 annual result came in at $75214.0, up 5.22% from the prior year.
• Inventory rose to $104046.0 in Q2 2026 per BYAH's latest filing, from $75214.0 in the prior quarter.
• Over the last five years, Inventory for BYAH reached as high as $104046.0 in Q2 2026 and fell as low as $2647.0 in Q2 2025.
• A 4-year average of $69852.6 and a median of $75214.0 in 2025 frame the typical range for Inventory.
• Annual changes were most pronounced in 2024 — Inventory declined 25.43% — and 2026, when it surged 3830.71%.
• Year by year, Inventory stood at $95870.0 in 2023, then dropped by 25.43% to $71486.0 in 2024, then climbed by 5.22% to $75214.0 in 2025, then surged by 38.33% to $104046.0 in 2026.
• According to Business Quant data, Inventory over the past three periods registered $104046.0, $75214.0, and $2647.0 for Q2 2026, Q4 2025, and Q2 2025 respectively.